Can a 1‑year‑old child use an intranasal corticosteroid spray?

Can You Use Intranasal Corticosteroid Spray on a 1-Year-Old?

Yes, you can use intranasal corticosteroid spray on a 1-year-old child, but only specific formulations are FDA-approved for this age group. Specifically, mometasone furoate (Nasonex) and fluticasone furoate (Veramyst) are approved for children as young as 2 years old, while most other intranasal corticosteroids require the child to be at least 4-6 years old 1.

Age-Specific FDA Approvals for Intranasal Corticosteroids

For a 1-year-old child, no intranasal corticosteroid is currently FDA-approved 1. The youngest approved ages are:

• Mometasone furoate (Nasonex): Approved for children ≥2 years old at 1 spray per nostril daily 1
• Fluticasone furoate (Veramyst): Approved for children ≥2 years old at 1-2 sprays per nostril daily 1
• Fluticasone propionate (Flonase): Approved for children ≥4 years old 1
• Budesonide, triamcinolone, flunisolide: Approved for children ≥6 years old 2, 1

Clinical Considerations and Safety

Intranasal corticosteroids are the most effective medication class for controlling allergic rhinitis symptoms (sneezing, itching, rhinorrhea, and nasal congestion) 2. However, their use in very young children requires careful consideration:

Safety Profile in Young Children

• When used at recommended doses, intranasal corticosteroids are not generally associated with clinically significant systemic side effects 2
• Studies have failed to demonstrate consistent, clinically relevant effects on the hypothalamic-pituitary-adrenal (HPA) axis, ocular pressure, cataract formation, or bone density 2
• Growth suppression has been reported only with long-term use of beclomethasone dipropionate that exceeded recommended doses or when administered to toddlers 2
• Newer agents like mometasone furoate and fluticasone propionate have lower bioavailability and thus a better safety profile for longer-term treatment 3, 4

Important Caveats for Children Under 2 Years

For a 1-year-old specifically, you should avoid intranasal corticosteroids unless there is a compelling clinical indication and close physician supervision, because:

1. No FDA approval exists for this age group 1
2. The narrow margin between therapeutic and toxic doses in infants increases the risk for cardiovascular and CNS side effects 2
3. Growth suppression concerns are heightened when administering corticosteroids to toddlers 2

Alternative Treatment Options for 1-Year-Olds

If treating nasal symptoms in a 1-year-old child:

• Second-generation oral antihistamines (cetirizine, loratadine) have been shown to be well tolerated and have a very good safety profile in young children 2
• Avoid OTC cough and cold medications (decongestants and first-generation antihistamines) in children below 2 years of age due to safety concerns, including 43 fatalities in children below age 1 year associated with decongestants 2
• Nasal saline irrigation can be considered as a non-pharmacologic option

When to Consider Off-Label Use

If you are considering off-label use of intranasal corticosteroids in a 1-year-old:

• Ensure a proper diagnosis of allergic rhinitis rather than treating symptoms alone, as this may delay appropriate diagnosis and management 5
• Use only under close physician supervision with regular monitoring for local side effects (nasal irritation, bleeding, septal perforation) and systemic effects 2
• Consider mometasone furoate or fluticasone propionate if treatment is necessary, as these have the best safety profiles 3, 4
• Use the lowest effective dose and monitor growth velocity as an indicator of systemic effect 2